Mustang Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-51.6	-77.53	-66.37	-60.02	-46.39	-30.66	-31.29	-12.65
Depreciation & Amortization	2.23	3.03	2.31	1.79	1.37	0.63	0	0
Share-Based Compensation	0.57	2.28	3.31	2.99	2.66	4.96	2.01	0
Other Operating Activities	-0.67	7.15	7.09	17.92	8.78	5.83	16.33	8.53
Operating Cash Flow	-49.48	-65.07	-53.67	-37.32	-33.58	-19.24	-12.95	-4.13
Capital Expenditures	5.94	-2.59	-3.99	-1.93	-2.35	-6.87	-0.42	0
Change in Investments	0	0	0	0	17.6	8.5	-26	0
Other Investing Activities	-0.05	-0.37	-1.38	-2.49	-1.35	-1.08	-2.63	-
Investing Cash Flow	5.89	-2.95	-5.37	-4.41	13.91	0.56	-29.05	0
Share Issuance / Repurchase	4.74	6.83	72.23	97.38	54.14	0.18	50.3	35.01
Debt Issued / Paid	-30.38	30	0	-15.75	13.61	0	-0.32	-3.38
Other Financing Activities	-0.45	-2.77	-1.38	-3.51	-2.63	-	-	-
Financing Cash Flow	-26.08	34.06	70.85	78.12	65.12	0.18	49.98	31.63
Net Cash Flow	-69.67	-33.96	11.81	36.39	45.44	-18.51	7.98	27.5
Free Cash Flow	-43.54	-67.65	-57.65	-39.24	-35.93	-26.11	-13.37	-4.13
Free Cash Flow Per Share	-5.06	-8.80	-9.84	-11.19	-14.94	-14.54	-7.94	-5.62

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).